Non-Hodgkin lymphoma
Basic details
Preferred term: Non-Hodgkin lymphoma
Alt. terms: non-Hodgkin's lymphoma
HPO term: Non-Hodgkin lymphoma
HPO code: HP:0012539
GenIA ID: 54
Last updated on: 2021-12-10 17:55:48
Cross ref. with other ontologies
NCIT: -
MESH: -
EFO: -
OAE: -
SNOMEDCT: -
ICD10: C85.9
Description
A type of lymphoma characterized microscopically by the absence of multinucleated Reed-Sternberg cells.
Hierarchical classification
PARENT terms
TERM
Non-Hodgkin lymphoma
Reported patients added to GenIA DB
| SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
|---|---|---|---|---|---|---|---|
| 101015 | M | 210203 | - | German | Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.MM:II.1]; PMID:29729943 [Fam.MM:II.1(87)]; PMID:34975878 [Fam.F002:P002]; PMID:31857261 [Patient 3] |
| 101023 | M | 210731 | 50,51 | German | B-cell lymphoma,Non-Hodgkin lymphoma | PMID:34975878 [Fam.F008:P008] | |
| 101037 | M | 210182 |
- | Caucasian | Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.4(B.II.3)]; PMID:30250467 [B.II.3]; PMID:29729943 [Fam.B:II.4(B.II.3 (15))]; PMID:27418640 [P13(5)] |
| 101076 | F | 210226 | 53 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F041:P041] | |
| 101088 | M | 211560 | 38 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F054:P054] | |
| 101121 | M | 210784 | 47 | German | Lymphoma | PMID:34975878 [Fam.F072:P072] | |
| 101133 | M | 210896 | 38 | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 13 | PMID:34975878 [Fam.F082:P082] | |
| 101155 | M | 210235 | - | German | Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [JJ.II.I]; PMID:29729943 [Fam.JJ:II.1(83)]; PMID:34975878 [Fam.F098:P098] |
| 101160 | F | 211433 | - | Non-Hodgkin lymphoma | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F101:P101] | |
| 101441 | M | 212174 | 19 | North American | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:26206937 [P6] |
| 101473 | F | 212398 | 2 | Spanish | B-cell lymphoma | Immunodeficiency, common variable, 8 | PMID:30386343 [Patient(II.1)] |
| 101549 | F | 212463 | - | British | Lymphoma | Activated p110-delta syndrome 1 | PMID:24136356 [Fam.E:I.1(P13)] |
| 101808 | F | 211441 | 34,- | Follicular lymphoma,Non-Hodgkin lymphoma | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F265:P265] | |
| 101904 | F | 212312 | - | British | B-cell lymphoma | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES09] |
| 102175 | M | 210725 |
- | Caucasian | Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.H:II.1]; PMID:29729943 [Fam.H:II.1(29)] |
| 102222 | M | 214917 | 44 | German | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [BY.I.1]; PMID:35486341 [P074]; PMID:150198 [Fam.DJ:467]; PMID:36105815 [W295C] |
| 102225 | M | 214920 | - | Romanian | Lymphoma | Immunodeficiency 40 | PMID:35486341 [P063] |
| 102660 | M | 214979 |
1 | Moroccan | B-cell lymphoma | Immunodeficiency 8 | PMID:23522482 [Fam.P3:V.1(P1)] |
| 102661 | F | 214979 |
1 | Moroccan | B-cell lymphoma | Immunodeficiency 8 | PMID:23522482 [Fam.P3:V.2(P2)] |
| 102803 | F | 214991 |
16,16 | North American | B-cell lymphoma,Lymphoma | Immunodeficiency 8 | PMID:25073507 [P1(II.2)] |
| 102934 | F | 215035 |
- | Caucasian | B-cell lymphoma | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P23]; PMID:33464451 [P14(III.1)]; PMID:37419334 [P23(22)] |
| 103027 | F | 215087 |
- | Hungarian | B-cell lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN133]; PMID:18706697 [Fam.2:I.2(N1)] |
| 103051 | M | 215095 |
9 | Finnish | B-cell lymphoma | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F1:II.7(P1)] |
| 103076 | F | 215099 |
3 | Omani | B-cell lymphoma | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F5:V.5(P6)] |
| 103292 | F | 215114 | 49 | German | B-cell lymphoma | Immunodeficiency 82 with systemic inflammation | PMID:33782605 [P5] |
| 103293 | M | 215115 | 51 | B-cell lymphoma | Immunodeficiency 82 with systemic inflammation | PMID:33782605 [P6] | |
| 103788 | M | 215242 |
- | South Korean | Lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:19348930 [Patient(II.1)] |
| 103929 | M | 215279 | 34 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K10:P12] |
| 103938 | M | 215285 | 17 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K16:P20] |
| 103946 | F | 215290 | 8 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K20:P25] |
| 103947 | F | 215291 | 21 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K21:P26] |
| 104326 | F | 215465 | - | B-cell lymphoma | B-cell lymphomas 1 | PMID:24837465 [4] | |
| 104327 | M | 215466 | - | B-cell lymphoma | B-cell lymphomas 1 | PMID:24837465 [5] | |
| 104329 | U | 215468 | - | NK/T-cell lymphoma | NK/T-cell lymphomas 1 | PMID:25586472 [S614R] | |
| 104330 | U | 215469 | - | NK/T-cell lymphoma | NK/T-cell lymphomas 1 | PMID:25586472 [D661Y] | |
| 104331 | U | 215470 | - | NK/T-cell lymphoma | NK/T-cell lymphomas 1 | PMID:25586472 [A702T] | |
| 104357 | M | 215496 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P2] |
| 104361 | M | 215500 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P6] |
| 104365 | F | 215504 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P10] |
| 104462 | F | 215532 |
49 | European | Follicular lymphoma | Early-onset atopic inflammation | PMID:36884218 [Fam.F:I.1(P7)]; PMID:37316763 [Fam.Patient:I.2(mother)] |
| 104845 | F | 215579 |
35 | European | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [Fam.NZ:II.2(II.2)]; PMID:26279205 [Fam.NZ:II.2(II2)]; PMID:29403474 [Fam.NZ (5):II.2(II2)]; PMID:29806948 [Fam.NZ:II.2(II.2)]; PMID:30323807 [Fam.2:II.2(II.2)]; PMID:150198 [Fam.AC:II.2(109)] |
| 105173 | M | 215659 | - | Non-Hodgkin lymphoma | PMID:27102614 [Fam.A:I.1(father)] | ||
| 105177 | M | 215661 | - | Caucasian | Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [L.II.2]; PMID:29729943 [Fam.L:II.2(L.II.2 (36))]; PMID:27102614 [Fam.C:II.2(4)] |
| 105256 | F | 210008 |
- | German | B-cell lymphoma | PMID:32278790 [Fam.AU:I.2(I.2)]; PMID:150198 [Fam.AM:I.2(153)] | |
| 105280 | M | 215685 |
68 | European | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [Fam.B:I.1(I.1)]; PMID:29477724 [Fam.B:I.1(I:1)]; PMID:150198 [Fam.AV:I.1(242)] |
| 105302 | M | 215686 |
- | European | B-cell lymphoma | NFKB1 insufficiency | PMID:32278790 [Fam.C:II.5(II.5)]; PMID:29477724 [Fam.C:II.5(II:5)]; PMID:150198 [Fam.AW:II.5(251)] |
| 105314 | F | 215689 | 59 | European | Follicular lymphoma | NFKB1 insufficiency | PMID:32278790 [F.II.1]; PMID:29477724 [Fam.F:II.1(II:1)]; PMID:150198 [Fam.AZ:265]; PMID:36105815 [V98D] |
| 105338 | U | 215700 | 63 | European | T-cell lymphoma | NFKB1 insufficiency | PMID:32278790 [K.II.1]; PMID:29477724 [Fam.K:II.1(II:1)]; PMID:150198 [Fam.BE:280] |
| 105463 | M | 215772 |
51 | Russian | B-cell lymphoma | NFKB1 insufficiency | PMID:32278790 [AO.I.1]; PMID:150198 [Fam.BS:I.1(317)]; PMID:31803180 [Fam.B:I.1(S2)]; PMID:34619682 [P.122] |
| 105591 | F | 215821 | 16 | Caucasian | Non-Hodgkin lymphoma | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.2:II.1(F2P2)] |
| 105910 | F | 215905 | -,45 | Caucasian | Lymphoma,Non-Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [K.II.1]; PMID:29729943 [Fam.K:II.1(K.II.1 (33))] |
| 106042 | M | 215927 | 22,-,22 | North American | Burkitt lymphoma,Lymphoma,Non-Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [FF.II.1]; PMID:29729943 [Fam.FF:II.1(FF.II.1 (77))] |
| 106090 | M | 215946 |
- | Saudi | B-cell lymphoma | T-cell immunodeficiency with thymic aplasia | PMID:33464451 [P11]; PMID:37419334 [P11(27)]; PMID:31151968 [Fam.1:II.2(Patient)] |
| 106145 | M | 215954 | 6 | Slovak | B-cell lymphoma | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:33464451 [P9]; PMID:37419334 [P9(27)] |
| 106164 | M | 215963 | - | Turkish | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P8] |
| 106166 | M | 215965 | - | Turkish | Follicular lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P10] |
| 106169 | F | 215968 | - | Turkish | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P13] |
| 106222 | F | 215975 |
54 | Finnish | B-cell lymphoma | NFKB1 insufficiency | PMID:150198 [Fam.FM:IV.8(707)]; PMID:36356849 [Fam.2:IV.8(F2:IV:8)] |
| 106251 | M | 215977 | - | Caucasian | B-cell lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.UU:III.13(UU.III.9 (112))]; PMID:29305966 [Fam.IV.2:III.7(III.3)] |
| 106256 | F | 215977 | - | Caucasian | Lymphoma | PMID:30250467 [UU.III.3]; PMID:29729943 [Fam.UU:III.4(UU.III.3 (108))]; PMID:29305966 [Fam.IV.2:III.9(III.11)] | |
| 106321 | M | 215688 |
- | European | Lymphoma | PMID:150198 [Fam.AY:I.1(261)]; PMID:36105815 [Fam.I281M:I.1(father)] | |
| 106840 | M | 216167 | - | SouthEast Asian | Burkitt lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:35242131 [3] |
| 106939 | M | 216189 |
49 | Caucasian | B-cell lymphoma | NFKB1 insufficiency | PMID:150198 [Fam.FW:II.1(772)]; PMID:38423196 [Fam.1:II.1(P1)] |
| 107136 | M | 216355 | - | T-cell lymphoma | NK/T-cell lymphomas 1 | PMID:23563237 [PTCL-1] | |
| 107137 | F | 216356 | - | T-cell lymphoma | NK/T-cell lymphomas 1 | PMID:23563237 [PTCL-2] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).